Edesa Biotech Inc (EDSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2012 | 08-2012 | 09-2011 | 09-2007 | |
| Cash Flows From Operating Activities | ||||
| Net Income | N/A | -5,529 | N/A | N/A |
| Depreciation Amortization | 110 | 112 | N/A | N/A |
| Accounts receivable | N/A | 30 | N/A | N/A |
| Other Working Capital | 440 | 454 | N/A | N/A |
| Other Operating Activity | 690 | 986 | 0 | 0 |
| Operating Cash Flow | $1,240 | $-3,948 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -70 | -78 | N/A | N/A |
| Investing Cash Flow | $-70 | $-78 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | N/A | 877 | N/A | N/A |
| Other Financing Activity | 870 | 0 | 0 | 0 |
| Financing Cash Flow | $870 | $877 | $N/A | $N/A |
| Exchange Rate Effect | N/A | 2 | N/A | N/A |
| Beginning Cash Position | N/A | 4,146 | N/A | N/A |
| End Cash Position | N/A | 999 | N/A | N/A |
| Net Cash Flow | $2,040 | $-3,147 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | 1,240 | -3,948 | N/A | N/A |
| Capital Expenditure | N/A | -78 | N/A | N/A |
| Free Cash Flow | 1,240 | -4,026 | 0 | 0 |